Target intelligence / Profile preview

Macleaya cordata extract (MCE) (MCE)

Target
MCE
Molecular classification
Isoquinoline alkaloids, Botanical extract, Benzophenanthridine alkaloids
01

Overview

Macleaya cordata extract is a botanical mixture derived from the Plume Poppy, a plant native to East Asia. It is primarily composed of isoquinoline alkaloids, most notably sanguinarine and chelerythrine, which are responsible for its biological activity (Source: PubMed, PMID: 30582953). Although often discussed in pharmacological contexts, it is not a single molecular target but a complex substance containing multiple bioactive compounds. The extract is widely used as a natural antimicrobial and anti-inflammatory agent in veterinary medicine and animal feed (Source: EFSA Journal). Its components act by inhibiting the NF-kappaB signaling pathway and various enzymes like Na+/K+-ATPase (Source: PubChem). Research has explored its potential in treating inflammatory conditions and as an anticancer agent due to its ability to induce apoptosis in malignant cells. However, its use in humans is limited by significant safety concerns, including potential hepatotoxicity and genotoxicity associated with its primary alkaloid, sanguinarine (Source: NIH). In drug discovery, it serves as a source of chemical scaffolds rather than a specific therapeutic receptor or enzyme.

Other names
Plume poppy extractBocconia cordata extractSangrovitMacleaya cordata alkaloids
02

Mechanism of action

The extract exerts its effects through its constituent alkaloids, which inhibit the NF-kappaB signaling pathway, suppress pro-inflammatory cytokines such as TNF-alpha and IL-6, and interfere with the Na+/K+-ATPase pump.

03

Biological functions

Antimicrobial activityAnti-inflammatory activityApoptosis inductionEnzyme inhibitionGrowth promotion
04

Disease associations

InflammationBacterial infectionCancerGastrointestinal disorders
05

Safety considerations

CytotoxicityHepatotoxicityPotential genotoxicityMucosal irritationDNA intercalation
06

Interacting drugs

Sanguinarine

3 more in the full profile.

07

Biomarkers

Sanguinarine concentrationChelerythrine concentrationNF-kappaB activity levels

Beyond the preview

Go deeper on Macleaya cordata extract (MCE) (MCE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macleaya cordata extract (MCE) (MCE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call